Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Genscript Biotech ( (HK:1548) ) is now available.
Genscript Biotech Corporation has announced a board meeting scheduled for August 16, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the possibility of declaring an interim dividend, which could have implications for the company’s financial strategy and shareholder returns.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotech industry. It focuses on providing innovative products and services, although specific details about its market focus or primary offerings are not provided in the announcement.
YTD Price Performance: 68.70%
Average Trading Volume: 29,093,826
Technical Sentiment Signal: Buy
Current Market Cap: HK$36.01B
Find detailed analytics on 1548 stock on TipRanks’ Stock Analysis page.